|
SLC25A44 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.66784380645413E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.30049999991222E-07 |
| Normal-vs-Stage2 |
1.84277999999427E-05 |
| Normal-vs-Stage3 |
4.91628959764512E-12 |
| Normal-vs-Stage4 |
3.3182001590859E-10 |
| Stage1-vs-Stage2 |
1.581760E-01 |
| Stage1-vs-Stage3 |
9.037600E-03 |
| Stage1-vs-Stage4 |
5.701600E-03 |
| Stage2-vs-Stage3 |
6.613200E-01 |
| Stage2-vs-Stage4 |
4.333600E-01 |
| Stage3-vs-Stage4 |
5.851600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.18864942730579E-12 |
| Normal-vs-AfricanAmerican |
1.9727599999908E-05 |
| Normal-vs-Asian |
4.269400E-01 |
| Caucasian-vs-AfricanAmerican |
8.648800E-01 |
| Caucasian-vs-Asian |
4.301000E-01 |
| AfricanAmerican-vs-Asian |
4.456000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
2.560700E-03 |
| Male-vs-Female |
6.64679999928808E-08 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.40290001837684E-09 |
| Normal-vs-Age(41-60Yrs) |
4.10260003746998E-09 |
| Normal-vs-Age(61-80Yrs) |
5.64825963778048E-12 |
| Normal-vs-Age(81-100Yrs) |
1.839960E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.646240E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.500000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.125600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.689600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.713400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.929800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.822600E-01 |
| Normal-vs-Grade 2 |
1.39119999964521E-07 |
| Normal-vs-Grade 3 |
1.4747003618254E-10 |
| Normal-vs-Grade 4 |
1.62470037423645E-12 |
| Grade 1-vs-Grade 2 |
1.697220E-01 |
| Grade 1-vs-Grade 3 |
1.535840E-02 |
| Grade 1-vs-Grade 4 |
1.291810E-02 |
| Grade 2-vs-Grade 3 |
8.396100E-02 |
| Grade 2-vs-Grade 4 |
8.34049999953734E-07 |
| Grade 3-vs-Grade 4 |
1.216860E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.132200E-02 |
| Normal-vs-ccB subtype |
1.62436730732907E-12 |
| ccA subtype-vs-ccB subtype |
1.62436730732907E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.73659999608478E-08 |
| Normal-vs-N1 |
1.58308000000051E-05 |
| N0-vs-N1 |
3.061400E-01 |
|
|
